Directly observed therapy for tuberculosis given twice weekly in the workplace in urban South Africa
- 1 November 1997
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 91 (6) , 704-707
- https://doi.org/10.1016/s0035-9203(97)90532-0
Abstract
Effective models of delivery of directly observed therapy (DOT) for tuberculosis in resource-poor settings are needed. Intermittent chemotherapy may be an important component of DOT delivered in the community as it means fewer visits to supervisors. There is no published evidence on the efficacy of twice weekly therapy given from the start of treatment without an intensive daily phase. We analysed data from 3 large cohort studies in a migrant, urban workforce in South Africa between 1975 and 1983. All patients received 4 drugs (isoniazid, rifampicin, pyrazinamide and streptomycin) twice weekly under direct observation by a nurse in the workplace. Of 444 patients, 378 (85·1%) completed treatment. Cure could be assessed in 362, and 348 (96·1%, 95% confidence interval 93·7–97·8%) were bacteriologically cured. Sputum status was assessed at 2–3 months in 343 patients and 309 (90·1%) were sputum negative. Eighteen patients relapsed (5·7%; patient-years of observation). DOT can be effectively delivered to a migrant, urban workforce, and 4-drug therapy given twice weekly under direct observation is efficacious.Keywords
This publication has 9 references indexed in Scilit:
- Efficacy of twice weekly treatment for tuberculosis given under direct observation in AfricaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1997
- Directly observed therapy for tuberculosis in rural South Africa, 1991 through 1994.American Journal of Public Health, 1996
- Tuberculosis control in resource-poor countries: alternative approaches in the era of HIVThe Lancet, 1995
- Tuberculosis in New York City — Turning the TideNew England Journal of Medicine, 1995
- Pulmonary Tuberculosis in HIV-Infected Patients in Zaire — A Controlled Trial of Treatment for Either 6 or 12 MonthsNew England Journal of Medicine, 1995
- High-compliance tuberculosis treatment programme in a rural communityThe Lancet, 1994
- Evaluation of New Anti-Infective Drugs for the Treatment and Prevention of TuberculosisClinical Infectious Diseases, 1992
- Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countriesThe Lancet, 1991
- A 62-Dose, 6-Month Therapy for Pulmonary and Extrapulmonary TuberculosisAnnals of Internal Medicine, 1990